The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Advanced Therapy Medicinal Products Market Over The Period 2026–2030?
The advanced therapy medicinal products market size has experienced rapid expansion in recent years. Projections indicate a rise from $51.34 billion in 2025 to $61.41 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.6%. Historically, the market’s development was influenced by factors such as the limited availability of advanced therapy products, a prevalent reliance on traditional biologics, nascent regulatory frameworks, the significant cost of gene and cell therapies, and restricted distribution channels.
The advanced therapy medicinal products market is projected to experience swift expansion in the coming years. This market is forecast to reach $124.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 19.3%. This projected growth is driven by factors such as progress in gene editing and stem cell therapies, increased funding for personalized medicine, a higher incidence of rare and chronic conditions, the broadening reach of hospital pharmacy and specialty clinic services, and the incorporation of AI-powered manufacturing and automated procedures. Key trends anticipated during this period encompass the increased acceptance of autologous and allogeneic treatments, the broadening use of gene editing and viral vector technologies, a greater emphasis on therapies for rare diseases, the incorporation of automation into therapy production, and stronger partnerships between hospitals and specialty clinics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25689&type=smp
Which Economic Or Industry Drivers Are Impacting The Advanced Therapy Medicinal Products Market?
The escalating need for personalized medicine is projected to drive the expansion of the advanced therapy medicinal products market in the future. Personalized medicine describes a medical approach that customizes treatment and prevention strategies according to an individual’s distinct genetic makeup, lifestyle, and surrounding environment. The heightened demand for personalized medicine primarily results from the increasing prevalence of chronic diseases, as it facilitates tailored treatments that improve patient outcomes and lessen side effects for specific individuals. Advanced therapy medicinal products enable personalized medicine through the provision of customized treatments, such as gene, cell, and tissue-engineered therapies, which target the unique genetic and biological profiles of individual patients. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from 6 in 2022. The newly sanctioned personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Hence, the rising demand for personalized medicine is a significant catalyst for the growth of the advanced therapy medicinal products market.
How Is The Advanced Therapy Medicinal Products Market Divided Into Its Major Segments?
The advanced therapy medicinal products market covered in this report is segmented –
1) By Product: Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products
2) By Technology: Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes
3) By Application: Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Somatic Cell Therapy Medicinal Products: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy, Natural Killer Cell Therapy
2) By Tissue Engineered Medicinal Products: Autologous Tissue-Engineered Products, Allogeneic Tissue-Engineered Products, Scaffold-Based Tissue Engineering, Scaffold-Free Tissue Engineering, Skin Substitutes
3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Gene Editing Therapies
How Are Trends Transforming The Advanced Therapy Medicinal Products Market Landscape?
Leading firms within the advanced therapy medicinal products (ATMP) sector are prioritizing the creation of novel therapeutic options, including gene editing cell therapies. Their aim is to provide precise and potentially restorative treatments for ailments such as ß thalassemia and sickle cell disease. These gene editing cell therapies entail harvesting a patient’s hematopoietic stem cells, followed by the precise modification of their genome outside the body (ex vivo), frequently utilizing CRISPR Cas9 technology to rectify detrimental mutations or activate advantageous genetic pathways. This process presents an individualized option compared to conventional allogeneic bone marrow transplantation, which necessitates donor compatibility and is associated with risks like graft versus host disease. An illustrative example is the approval granted by the US Food and Drug Administration (FDA) in January 2024 to Vertex Pharmaceuticals, a US-based biotechnology firm, for CASGEVY (exagamglogene autotemcel, or exa cel). This is a CRISPR Cas9 based gene editing cell therapy specifically for transfusion dependent ß thalassemia. This particular therapy employs autologous CD34+ stem and progenitor cells, modifying the erythroid specific BCL11A enhancer to increase fetal hemoglobin levels. It has shown lasting clinical benefits, offering the prospect of achieving transfusion independence for numerous patients and substantially diminishing or removing the necessity for ongoing blood transfusions.
Who Are The Prominent Organizations Shaping The Advanced Therapy Medicinal Products Market?
Major companies operating in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc
Read the full advanced therapy medicinal products market report here:
What Are The Top-Performing Regions Within The Advanced Therapy Medicinal Products Market?
North America was the largest region in the advanced therapy medicinal products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Advanced Therapy Medicinal Products Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25689&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Market 2026, By The Business Research Company
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Herbal Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/herbal-medicine-global-market-report
Anti Inflammatory Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model